Skip to main content
. 2021 Sep 15;13(18):4630. doi: 10.3390/cancers13184630

Figure 5.

Figure 5

Niclosamide and pyrvinium inhibit the migration of osteosarcoma cells at non-cytotoxic μM concentration. (A) Representative migration images of MG-63 and SAOS-2; scale bar, 200 μm. (B) The migratory activity of MG-63 and SAOS-2 cells treated with 0.25 µM niclosamide and 0.03 μM pyrvinium using transwell migration assay. Results are representative of five independent experiments (error bars, ±SD. ** p < 0.01 versus DMSO).